Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Voyageur Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	0.44	0.27	0.17	0	0.03	0.81
Short-Term Investments	0	0	0	0	0.01	0.01
Cash & Short-Term Investments	0.44	0.27	0.17	0.01	0.04	0.82
Cash Growth	16.11%	60.03%	2927.20%	-85.11%	-95.42%	27500.91%
Other Receivables	-	0.13	0.05	0.04	0.02	0.04
Receivables	0.05	0.13	0.05	0.04	0.02	0.04
Inventory	0.12	0.05	0.07	0.01	0.01	0.01
Prepaid Expenses	0.03	0.14	0.07	0.04	0.09	0.02
Total Current Assets	0.64	0.6	0.36	0.09	0.16	0.89
Property, Plant & Equipment	2.56	2.49	2.23	2.06	1.92	1.67
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01	0.01
Total Assets	3.22	3.11	2.6	2.16	2.1	2.57

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Accounts Payable	1.36	0.82	0.91	0.22	0.52	0.55
Accrued Expenses	0.97	-	-	-	-	-
Short-Term Debt	-	-	0.02	-	-	-
Current Portion of Leases	-	-	-	-	-	0.02
Current Unearned Revenue	0.16	0.1	-	-	-	-
Other Current Liabilities	0.28	0.89	1.17	0.46	0.07	0.05
Total Current Liabilities	2.81	1.81	2.09	0.67	0.59	0.62
Long-Term Debt	-	0.04	0.04	0.04	0.03	0.03
Other Long-Term Liabilities	-	-	0.01	0.01	0.01	0.01
Total Liabilities	2.81	1.85	2.15	0.73	0.63	0.66

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Common Stock	12.61	12.64	9.14	8.69	7.55	6.33
Additional Paid-In Capital	3.77	2.96	2.13	1.86	1.64	1.55
Retained Earnings	-15.99	-14.37	-10.84	-9.13	-7.73	-5.97
Comprehensive Income & Other	0.02	0.02	0.02	0.01	-	-
Shareholders' Equity	0.41	1.25	0.45	1.44	1.46	1.91
Total Liabilities & Equity	3.22	3.11	2.6	2.16	2.1	2.57

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Total Debt	0.04	0.04	0.06	0.04	0.03	0.04
Net Cash (Debt)	0.4	0.23	0.11	-0.03	0.01	0.78
Net Cash Growth	18.00%	104.70%	-	-	-98.46%	-
Net Cash Per Share	0.00	0.00	0.00	-0.00	0.00	0.01
Filing Date Shares Outstanding	226.34	178.59	139.47	138.81	132.7	102.02
Total Common Shares Outstanding	179.48	178.59	139.47	132.7	115.43	101.82
Working Capital	-2.17	-1.22	-1.74	-0.59	-0.43	0.27
Book Value Per Share	0.00	0.01	0.00	0.01	0.01	0.02
Tangible Book Value	0.41	1.25	0.45	1.44	1.46	1.91
Tangible Book Value Per Share	0.00	0.01	0.00	0.01	0.01	0.02
Machinery	0.02	0.02	0.02	0.02	0.02	0.08

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error